RX DM
ActiveSummary
RX DM has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €121k and a net result of €51k. Equity is growing by ~7.8% per year across the filed fiscal years. Its solvency ranks better than 51% of 19913 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability100=
Solvency93▼-7
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €11k at 30 days acceptable
Liquidity ample (current ratio 2.07 against 1.43 in 2023; short-term debt: 31.9% and cash: 50.8% of total assets), and 31.9% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-08-2025, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
not confirmed
2024
28 d late
2023
26 d late
2022
24 d late
2021
29 d late
2020
26 d late
2019
18 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€121k=
2023 · €121k
2019: €49klowest in 6 years
2020: €92k▲ +87.7% vs 2019
2021: €149k▲ +61.8% vs 2020highest in 6 years
2022: €121k▼ -19.2% vs 2021
2023: €121k● 0.0% vs 2022
2024: €121k● 0.0% vs 2023
2019 → 2024
Total assets
€177k▲ 12.5%
2023 · €158k
2019: €360khighest in 6 years
2020: €330k▼ -8.4% vs 2019
2021: €229k▼ -30.7% vs 2020
2022: €196k▼ -14.3% vs 2021
2023: €158k▼ -19.7% vs 2022lowest in 6 years
2024: €177k▲ +12.5% vs 2023
2019 → 2024
Net result
€51k▲ 4.2%
2023 · €49k
2019: €31k
2020: €43k▲ +41.0% vs 2019
2021: €57k▲ +32.2% vs 2020highest in 6 years
2022: €1k▼ -97.9% vs 2021lowest in 6 years
2023: €49k▲ +3891% vs 2022
2024: €51k▲ +4.2% vs 2023
2019 → 2024
Working capital
€60k▲ 278%
2023 · €16k
2019: €-227klowest in 6 years
2020: €-137k▲ +39.5% vs 2019
2021: €-46k▲ +66.6% vs 2020
2022: €-29k▲ +37.2% vs 2021
2023: €16k▲ +155% vs 2022
2024: €60k▲ +278% vs 2023highest in 6 years
2019 → 2024
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€92k-€149k▲ 61.8%€121k▼ 19.2%€121k=€121k=
2020: €92klowest in 5 years
2021: €149k▲ +61.8% vs 2020highest in 5 years
2022: €121k▼ -19.2% vs 2021
2023: €121k● 0.0% vs 2022
2024: €121k● 0.0% vs 2023
Operating result€63k-€84k▲ 33.8%€6k▼ 93.0%€63k▲ 964%€66k▲ 4.5%
2020: €63k
2021: €84k▲ +33.8% vs 2020highest in 5 years
2022: €6k▼ -93.0% vs 2021lowest in 5 years
2023: €63k▲ +964% vs 2022
2024: €66k▲ +4.5% vs 2023
Net result€43k-€57k▲ 32.2%€1k▼ 97.9%€49k▲ 3,891%€51k▲ 4.2%
2020: €43k
2021: €57k▲ +32.2% vs 2020highest in 5 years
2022: €1k▼ -97.9% vs 2021lowest in 5 years
2023: €49k▲ +3891% vs 2022
2024: €51k▲ +4.2% vs 2023
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 4% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €177k
Fixed assets
€61k ▼ 42.2%
Current assets
€117k ▲ 121%
Equity and liabilities €177k
Equity
€121k =
Debt
€56k ▲ 53.5%
Debt's share of the balance-sheet total rises from 23.4% to 31.9%. Debt is higher.
Key figures and ratios
EBITDA
€111k▲
2023 · €110k
Cash flow
€96k▲
2023 · €96k
Current ratio
2.07▲
2023 · 1.43
Debt to equity
0.47▲
2023 · 0.30
ROE
42.1%▲
2023 · 40.4%
ROA
28.7%▼
2023 · 31.0%
Interest coverage
2553.78▼
2023 · 2816.27
Debt ≤ 1 year
€56k▲
2023 · €37k
Income taxes
€15k▲
2023 · €14k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 45 lines
Balance sheet
Code20232024
Assets
Total assets20/58€158k€177k▲
Fixed assets21/28€105k€61k▼
Intangible fixed assets21€96k€54k▼
Tangible fixed assets22/27€8k€7k▼
Furniture and vehicles24€1k€915▼
Other tangible fixed assets26€7k€6k▼
Current assets29/58€53k€117k▲
Amounts receivable within one year40/41€0€5k▲
Trade receivables40-€34
Other amounts receivable41€0€5k▲
Cash at bank and in hand54/58€4k€90k▲
Deferred charges and accrued income490/1€49k€21k▼
Equity and liabilities
Total equity and liabilities10/49€158k€177k▲
Equity10/15€121k€121k=
Contributions10/11€19k€19k=
Reserves13€102k€102k=
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€102k€102k=
Profit (loss) carried forward14€0€0=
Amounts payable17/49€37k€56k▲
Amounts payable within one year42/48€37k€56k▲
Trade debts44€3k€4k▲
Suppliers440/4€3k€4k▲
Taxes, remuneration and social security45€4k€34▼
Taxes450/3€4k€0▼
Remuneration and social security454/9-€34
Other amounts payable47/48€30k€53k▲
Accrued charges and deferred income492/3€0-
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€47k€45k▼
Other operating charges640/8€384€0▼
Gross operating margin9900€110k€111k▲
Operating profit (loss)9901€63k€66k▲
Financial income75/76B€0€50▲
Recurring financial income75€0€50▲
Financial charges65/66B€39€44▲
Recurring financial charges65€39€44▲
Profit (loss) for the period before taxes9903€63k€66k▲
Income taxes67/77€14k€15k▲
Profit (loss) for the period9904€49k€51k▲
Profit (loss) for the period to be appropriated9905€49k€51k▲
Appropriation of the result
Profit (loss) to be appropriated9906€49k€51k▲
Transfer from equity791/2€0-
Profit to be distributed694/7€49k€51k▲
Return on contributions (dividend)694€49k€51k▲
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €45k | €47k | €47k | €47k | €45k | ▼ 3.3% |
| Other operating charges640/8 | - | €348 | €348 | €384 | €0 | ▼ 100% |
| Gross operating margin9900 | €109k | €131k | €53k | €110k | €111k | ▲ 0.8% |
| Operating profit (loss)9901 | €63k | €84k | €6k | €63k | €66k | ▲ 4.5% |
| Financial income75/76B | - | - | €0 | €0 | €50 | - |
| Recurring financial income75 | - | - | €0 | €0 | €50 | - |
| Financial charges65/66B | - | €4k | €2k | €39 | €44 | ▲ 11.5% |
| Recurring financial charges65 | €2k | €4k | €2k | €39 | €44 | ▲ 11.5% |
| Profit (loss) for the period before taxes9903 | €61k | €80k | €4k | €63k | €66k | ▲ 4.5% |
| Income taxes67/77 | €18k | €23k | €2k | €14k | €15k | ▲ 5.9% |
| Profit (loss) for the period9904 | €43k | €57k | €1k | €49k | €51k | ▲ 4.2% |
| Profit (loss) for the period to be appropriated9905 | €43k | €57k | €1k | €49k | €51k | ▲ 4.2% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €330k | €229k | €196k | €158k | €177k | ▲ 12.5% |
| Fixed assets21/28 | €232k | €199k | €152k | €105k | €61k | ▼ 42.2% |
| Intangible fixed assets21 | €225k | €182k | €139k | €96k | €54k | ▼ 44.4% |
| Tangible fixed assets22/27 | €7k | €17k | €13k | €8k | €7k | ▼ 16.6% |
| Furniture and vehicles24 | - | €8k | €4k | €1k | €915 | ▼ 31.4% |
| Other tangible fixed assets26 | - | €9k | €8k | €7k | €6k | ▼ 13.9% |
| Current assets29/58 | €98k | €30k | €44k | €53k | €117k | ▲ 121% |
| Amounts receivable within one year40/41 | €9k | €0 | €3k | €0 | €5k | - |
| Trade receivables40 | - | €0 | - | - | €34 | - |
| Other amounts receivable41 | - | - | €3k | €0 | €5k | - |
| Cash at bank and in hand54/58 | €69k | €4k | €9k | €4k | €90k | ▲ 2,213% |
| Deferred charges and accrued income490/1 | - | €26k | €33k | €49k | €21k | ▼ 56.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €330k | €229k | €196k | €158k | €177k | ▲ 12.5% |
| Equity10/15 | €92k | €149k | €121k | €121k | €121k | = |
| Contributions10/11 | - | €19k | €19k | €19k | €19k | = |
| Reserves13 | €74k | €131k | €102k | €102k | €102k | = |
| Non-distributable reserves130/1 | - | €2k | €2k | €0 | - | - |
| Reserves not available under the articles1311 | - | €2k | €2k | €0 | - | - |
| Distributable reserves133 | - | €129k | €100k | €102k | €102k | = |
| Profit (loss) carried forward14 | - | - | €0 | €0 | €0 | - |
| Amounts payable17/49 | €238k | €79k | €76k | €37k | €56k | ▲ 53.5% |
| Amounts payable within one year42/48 | €236k | €76k | €73k | €37k | €56k | ▲ 53.5% |
| Trade debts44 | €2k | €248 | €3k | €3k | €4k | ▲ 34.4% |
| Suppliers440/4 | - | €248 | €3k | €3k | €4k | ▲ 34.4% |
| Taxes, remuneration and social security45 | - | €23k | €23k | €4k | €34 | ▼ 99.2% |
| Taxes450/3 | - | €23k | €23k | €4k | €0 | ▼ 100% |
| Remuneration and social security454/9 | - | €0 | - | - | €34 | - |
| Other amounts payable47/48 | - | €52k | €47k | €30k | €53k | ▲ 75.6% |
| Accrued charges and deferred income492/3 | - | €4k | €2k | €0 | - | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €43k | €57k | €1k | €49k | €51k | ▲ 4.2% |
| + Depreciation and write-downs630 | €45k | €47k | €47k | €47k | €45k | ▼ 3.3% |
| Operating cash flow (approximation) | €89k | €104k | €48k | €96k | €96k | ▲ 0.5% |
| Investment in fixed assets (approximation) | - | €-14k | €0 | €0 | €-1k | - |
| Change in cash | - | €-65k | €5k | €-5k | €86k | ▲ 1,846% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
26-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 26 days late
2023
31-12
Financial
Liquidity doublescurrent ratio 1.43
Current ratio from 0.61 to 1.43; short-term debt falls from €73k to €37k.
24-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 24 days late
2022
31-12
Financial
Weakest financial yearnet €1k ▼97.9%
Net result drops to €1k, the lowest in the series; recovery starts the following year.
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 29 days late
2021
31-12
Financial
Highest result since 2019net €57k ▲32.2%
Operating result €84k, net result €57k, both a record.
31-12
Financial
Equity above €100kEq €149k ▲61.8%
3 profitable years in a row build equity to €149k.
26-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 26 days late
2020
18-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 18 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2019
Ground area
794 m²
Building footprint
235 m²
Volume, LiDAR
1,276 m³
Parcel 23016C0137/00M002, Flanders · tallest building 10.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
RX DM
since 20192.286.579.911
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23016C0137/00M002 | Flanders | 794 m² | 1 · 235 m² | 10.5 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
NMC MED
BE 0727.589.278
Nandrin · Eq €120,661
CASSIOPÉE MÉDICAL
BE 1007.608.383
Etterbeek · Eq €120,811
MDK-anesthésie-réanimation
BE 0652.646.682
Chaumont-Gistoux · Eq €120,868
Dr. David Degrauwe
BE 1000.983.184
Schoten · Eq €120,558
Dr. Pieter Luyten
BE 0849.074.256
Zwevegem · Eq €120,900
Of 16,625 companies in sector 86220 we hold annual accounts for 7,979. 6,550 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded15-03-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
86910Medical imaging and medical laboratories
Contact
E-mail
dr.demunck@gmail.comDilbeek
Phone
+32(485)795944Dilbeek
Scores and ratios are computed by Checked and are not a credit decision.